Summary
The purpose of the present study was to evaluate the role of muscle glycogen synthase activity in the reduction of glucose uptake during hypoglycaemia. Six healthy young men were examined twice; during 120 min of hyperinsulinaemic (1.5 mU · kg−1 · min−1) euglycaemia followed by: 1) 240 min of graded hypoglycaemia (plasma glucose nadir 2.8 mmol/l) or 2) 240 min of euglycaemia. At 350–360 min a muscle biopsy was taken and indirect calorimetry was performed at 210–240 and 330–350 min. Hypoglycaemia was associated with markedly increased levels of adrenaline, growth hormone and glucagon and also with less hyperinsulinaemia. During hypoglycaemia the fractional velocity for glycogen synthase was markedly reduced; from 29.8±2.3 to 6.4±0.9%, p<0.05. Total glucose disposal was decreased during hypoglycaemia (5.58±0.55 vs 11.01±0.75 mg · kg−1 · min−1 (euglycaemia); p<0.05); this was primarily due to a reduction of non-oxidative glucose disposal (2.43±0.41 vs 7.15±0.7 mg · kg−1 · min−1 (euglycaemia); p<0.05), whereas oxidative glucose disposal was only suppressed to a minor degree. In conclusion hypoglycaemia virtually abolishes the effect of insulin on muscle glycogen synthase activity. This is in keeping with the finding of a marked reduction of non-oxidative glucose metabolism.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- HGP:
-
Hepatic glucose production
- Rd:
-
glucose disposal
- GH:
-
growth hormone
- 3-OHB:
-
3-hydroxybutyrate
- G 6-P:
-
glucose 6-phosphate
- NEFA:
-
non-esterified fatty acids
- PP-1:
-
phosphatase-1
- Ra:
-
rate of appearance
- Rd-nonox:
-
non-oxidative glucose disposal
- Rd-ox:
-
oxidative glucose disposal
- A0.5:
-
half-maximal activity
References
Cryer PE, Gerich JE (1985) Glucose counterregulation, hypoglycaemia and intensive insulin therapy in diabetes mellitus. N Engl J Med 313: 232–241
Campbell PJ, Gerich JE (1988) Mechanisms for prevention, development and reversal of hypoglycaemia. Adv Intern Med 33: 205–230
Gerich JE (1985) Sulfonylureas in the treatment of diabetes mellitus. Mayo Clin Proc 60: 439–443
Koch J, Muhlhauser I, Jorgens V et al. (1993) Incidence and management of severe hypoglycaemia in 403 type 1 (insulin-dependent) diabetic patients: follow-up 18 months after an intensified teaching and treatment programme. Diabetologia 25(2): 171–172
Deckert T, Paulsen J, Larsen M (1978) Prognosis of diabetics with diabetes onset before the age of 31. Survival, cause of death and complications. Diabetologia 14: 363–370
The DCCT research group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986
Sacca L, Sherwin R, Hendler R, Felig P (1979) Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic man. J Clin Invest 63: 849–857
Rizza A, Cryer P, Gerich JE (1979) Role of glucagon, catecholamines and growth hormone in human glucose counterregulation: effects of somatostatin and combined α- and Β-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycaemia. J Clin Invest 64: 62–71
De Feo P, Perriello G, De Cosmo S et al. (1986) Comparison of glucose counterregulation during short-term and prolonged hypoglycaemia in normal humans. Diabetes 35: 563–569
De Feo P, Perriello G, Ventura MM et al. (1987) The pancreatic-adrenocortical-pituitary clamp technique for study of counterregulation in humans. Am J Physiol 252:E565-E570
Bolli G, De Feo P, Perriello G et al. (1985) Role of hepatic autoregulation in the defence against hypoglycaemia in man. J Clin Invest 75: 1623–1631
Randle P, Garland P, Hales C et al. (1963) The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbance of diabetes mellitus. Lancet I: 785–789
Ferrannini E, Barrett EJ, Bevilacqua S et al. (1983) Effects of fatty acids on glucose production and utilisation in man. J Clin Invest 72: 1737–1747
Caprio S, Amiel S, Tamborlane WT, Gelfand AG, Sherwin S (1990) Defective free-fatty acid and oxidative glucose metabolism in IDDM during hypoglycaemia; influence of glycemic control. Diabetes 39: 134–141
Frizzell R, Campbell R, Cherrington A (1988) Gluconeogenesis and hypoglycaemia. Diabetes Metab Rev 4: 51–54
Caprio S, Sacca L, Tamborlane WV, Sherwin R (1988) Relationship between changes in glucose production and gluconeogenesis during mild hypoglycemia in humans. Metabolism 37: 707–710
Lecavalier L, Bolli G, Cryer P, Gerich J (1989) Contributions of gluconeogenesis and glycogenolysis during glucose counterregulation in normal humans. Am J Physiol 256:E844-E851
Abildgaard N, Ørskov L, Petersen JAK, Alberti KGMM, Schmilz O, MØller N (1995) Forearm substrate exchange during hyperinsulinaemia hypoglycaemia in humans. Diabet Med 12: 218–223
Capaldo BR, Napoli R, Guida R et al. (1995) Forearm muscle insulin resistance during hypoglycemia: role of adrenergic mechanisms and hypoglycemia per se. Am J Physiol 268: E248-E254
Cohen N, Rossetti L, Shlimovich P, Halberstam M, Hu M, Shamoon H (1995) Skeletal muscle glycogen metabolism during three hours of physiological hyperinsulinemia in humans. Diabetes 44: 423–430
Bak JF, MØller N, Schmitz O (1991) Effects of growth hormone on fuel utilisation and muscle glycogen synthase activity in normal humans. Am J Physiol 260: E736-E742
Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628–631
Ørskov H, Thomsen AG, Yde H (1968) Wick-chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 219: 193–195
Andersen L, Dinesen B, JØrgensen PN, Paulsen F, RØder ME (1993) Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39: 578–582
Erikkson BM, Persson AB (1982) Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography. J Chrom Biomed App 228: 143–154
Harrison J, Hodson AW, Skillin AW, Strappenbeck R, Ageus L, Alberti KGMM (1988) Blood glucose, lactate, pyruvate, glycerol, 3-hydroxy-butyrate and acatoacetate measurements in man using a centrifugal analyser with a fluorometric attachment. J Clin Chem Clin Biochem 26: 141–146
Bak JF, Pedersen O (1990) Exercise-enhanced activation of glycogen synthase in human skeletal muscle. Am J Physiol 258: E957-E963
Kochan RG, Lamb DR, Lutz DR, Perril CV, Reiman EM, Schendler KK (1979) Glycogen synthase activation in human skeletal muscle: effects of diet and exercise. Am J Physiol 236: E660-E666
Lowry OH, Passonneau JV (1972) A flexible system of enzymatic analysis. Academic Press New York
Sjögaard G, Adams RP, Saltin BR (1985) Water and ion shifts in skeletal muscle of humans with intense dynamics knee extension. Am J Physiol 248: R190-R196
Steele R (1959) Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82: 420–424
De Bodo R, Steele R, Altschuler N, Dunn A, Bishop J (1963) On the hormonal regulation of carbohydrate metabolism: studies with C14 glucose. Recent Progr Horm Res 19: 445–488
DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP (1981) The effect of insulin on the disposal of intravenous glucose; results from indirect calorimetry and hepatic and femoral venous catheterisation. Diabetes 30: 1000–1007
Verdonk C, Rizza RA, Gerich JE (1981) Effects of plasma glucose concentration on glucose utilisation and glucose clearance in normal man. Diabetes 30: 535–537
Yki-Jarvinen H, Bogardus C, Howard BV (1987) Hyperglycaemia stimulates carbohydrate oxidation in humans. Am J Physiol 253: E376-E382
Yki-Jarvinen H, Mott D, Young AA, Stone K, Bogardus C (1987) Regulation of glycogen synthase activity by glucose and insulin in human skeletal muscle. J Clin Invest 80: 95–100
Bjorntorp P, Sjostrom L (1978) Carbohydrate storage in man; speculation and some quantitative considerations. Metabolism 27 [Suppl 2]: 1853–1865
Bogardus C, Lillioja S, Stone K, Mott D (1984) Correlation between muscle glycogen synthase activity and insulin action in man. J Clin Invest 73: 1185–1190
Mandarino LJ, Wright KS, Verity LS et al. (1987) Effects of insulin on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase and glycogen synthase; evidence for their role in oxidative and nonoxidative glucose metabolism. J Clin Invest 80: 655–663
Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322: 223–228
Capaldo B, Napoli R, Di Marino L, Sacca L (1992) Epinephrine directly antagonizes insulin-mediated activation of glucose uptake and inhibition of free fatty acid release in forearm tissues. Metabolism 41: 1146–1149
Dent P, Lavoinne A, Nakielny S, Caudwell FB, Watt P, Cohen P (1990) The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature 348: 302–308
Nakielny S, Campbell DG, Cohen P (1991) The molecular mechanism by which adrenaline inhibits glycogen synthesis. Eur J Biochem 199: 713–722
Raz I, Katz A, Spencer M (1991) Epinephrine inhibits insulin-mediated glycogenesis but enhances glycolysis in human skeletal muscle. Am J Physiol 260: E430-E435
Challiss RAJ, Crabtree B, Newsholme EA (1987) Hormonal regulation of the rate of the glycogen/glucose-1-phosphate cycle in skeletal muscle. Eur J Biochem 163: 205–210
James DE, Burleigh KM, Kraegen EW (1986) In vivo glucose metabolism in individual tissues of the rat. J Biol Chem 261: 6366–6374
Fanelli CG, De Feo P, Porcellati F et al. (1992) Adrenergic mechanisms contribute to the late phase of hypoglycaemic glucose counterregulation in humans by stimulating lipolysis. J Clin Invest 89: 2005–2013
Fanelli C, Calderone S, Epifano L et al. (1993) Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilisation in humans. J Clin Invest 92: 1617–1622
Fanelli C, Pampanelli S, Ciofetta M, Del Sindaco P, Lepore M, Bolli GB (1995) Sustained lipolysis is largely responsible for post-hypoglycemic insulin resistance in humans. Diabetes 44 [Suppl]: 4 (Abstract)
MØller N, Butler PC, Antsiferov MA, Alberti KGMM (1989) Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia 32: 105–110
De Feo P, Perriello G, Torlone E et al. (1989) Contribution of Cortisol to glucose counterregulation in humans. Am J Physiol 257: E35-E42
Rizza RA, Mandarino LJ, Gerich JE (1981) Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilisation due to a postreceptor defect of insulin action. J Clin Endocrinol Metab 54: 131–138
Baron AD, Wallace P, Brechtel G (1987) In vivo regulation of non-insulin-mediated and insulin-mediated glucose uptake by cortisol. Diabetes 36: 1230–1237
Corderre L, Srivastava AS, Chiasson J-L (1992) Effect of hypercorticism on regulation of skeletal muscle glycogen metabolism by insulin. Am J Physiol 262: E427-E433
Thiebaud D, Jacot E, DeFronzo RA, Maeder E, Jequier E, Felber J (1982) The effect of graded doses of insulin on total glucose uptake, glucose oxidation and glucose storage in man. Diabetes 31: 957–963
Shamoon H, Friedman S, Canton C, Zacharowicz L, Hu M, Rossetti L (1994) Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus. J Clin Invest 93: 2562–2571
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ørskov, L., Bak, J.F., Abildgård, N. et al. Inhibition of muscle glycogen synthase activity and non-oxidative glucose disposal during hypoglycaemia in normal man. Diabetologia 39, 226–234 (1996). https://doi.org/10.1007/BF00403967
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00403967